前哨淋巴结活检与即刻两阶段假体乳房再造:倾向性评分匹配分析
连续纳入2011年1月至2021年5月行全乳切除与即刻两阶段假体乳房再造的女性患者,按1:1最近邻匹配(卡钳值0.01)匹配后纳入320例再造(每组160例),比较术中行前哨淋巴结活检与未行腋窝手术者的结局。前哨淋巴结活检组30天血清肿发生率16.3% vs 8.1%(p=0.039),完成门诊扩张时间与扩张器更换假体时间两组相当;感染、血肿及因并发症行非计划手术率两组无差异。
要点
- 匹配后每组160例再造,前哨淋巴结活检组30天血清肿发生率16.3%,未行腋窝手术组8.1%(p=0.039)。
- 两组完成门诊扩张时间和扩张器更换假体时间相当。
- 感染、血肿及因并发症行非计划手术率两组无差异。
核心结论
- 在全乳切除与组织扩张器即刻假体乳房再造同时行前哨淋巴结活检,较未行腋窝手术的再造增加血清肿形成风险。
- 感染率、血肿率及因并发症行非计划手术率两组无差异。
研究设计与样本
- 回顾性队列研究,连续纳入2011年1月至2021年5月行全乳切除与即刻两阶段假体乳房再造的女性患者。
- 采用1:1最近邻匹配且不替换,卡钳宽度0.01,匹配变量包括年龄、糖尿病、高血压、高脂血症、乳房切除术前放疗、新辅助化疗、假体置入平面、乳房切除标本重量、引流管数量及扩张器放疗。
- 倾向性评分匹配后纳入320例两阶段即刻假体乳房再造,每组160例。
主要发现
- 匹配后两组相关手术变量具有可比性。
- 前哨淋巴结活检组30天血清肿发生率16.3%,未行腋窝手术组8.1%(p=0.039)。
- 前哨淋巴结活检组与未行腋窝手术组完成门诊扩张时间相当。
- 前哨淋巴结活检组与未行腋窝手术组扩张器更换假体时间相当。
- 感染率、血肿率及因并发症行非计划手术率两组无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are important differences between patients requiring sentinel lymph node biopsy (SLNB) and those who do not require axillary surgery at the time of breast reconstruction. We aimed to perform a propensity score-matched analysis to evaluate the impact of SLNB at the time of immediate implant-based breast reconstruction (IBBR) with tissue expanders compared with IBBR alone. METHODS: Consecutive female patients undergoing total mastectomy and immediate two-stage IBBR between January 2011 and May 2021 were included. A 1:1 nearest-neighbor matching method without replacement was implemented with a caliper width of 0.01. Patients were matched for age, diabetes, hypertension, hyperlipidemia, premastectomy radiotherapy, neoadjuvant chemotherapy, the plane of prosthesis placement, mastectomy specimen weight, number of drains, and radiation of the expander. RESULTS: We included 320 two-stage immediate IBBRs after propensity score matching, 160 reconstructions per group. Relevant surgical variables were comparable between groups. A higher rate of 30-day seroma formation was reported in immediate reconstructions that had SLNB at the time of mastectomy compared with reconstructions that did not have axillary surgery (16.3% versus 8.1%, p = 0.039). The time to complete outpatient expansions and time for expander-to-implant exchange were comparable between patients who underwent IBBRs with SLNB and those who did not. CONCLUSION: SLNB performed at the time of mastectomy and IBBR with tissue expander increased the risk of seroma formation compared with reconstructions that did not have axillary surgery. The rate of infection, hematoma, and unplanned procedures to manage complications did not differ between groups.
引用
- Escandón JM, Aristizábal A, Christiano JG, et al. Sentinel lymph node biopsy and immediate two-stage implant-based breast reconstruction: A propensity score-matched analysis. J Plast Reconstr Aesthet Surg. 2023. PMID: 37413737. doi:10.1016/j.bjps.2023.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。